Singapore's Genesis hits first close on second venture debt fund
Singapore-based Genesis Alternative Ventures has reached a first close on its second venture debut fund, having raised nearly half the overall target of USD 150m.
The firm began reaching out to investors late last year and formally launched in early 2022. About 80% of the capital in the first close - which came last month - is from existing LPs. These include Sassoon...
Co-Stone leads $43m round for China biosynthesis player
Co-Stone Capital Management has led a CNY 300m (USD 43m) Series B round for Readline, a Shenzhen-based company that specialises in synthetic biology.
Australia’s Heal Partners closes debut fund on $137m
Australia’s Heal Partners, a health, education, and lifestyle-focused venture capital firm, has closed its first fund on AUD 200m (USD 137m). The target was AUD 100m.
US regulator gets access to Chinese audits
The threat of delisting that has haunted Chinese companies that trade on US exchanges appears to have receded after the US regulators announced they had gained full access to the audits of these companies for the first time.